doi: 10.3109/13550289909029751.
Chemokines in chronic progressive neurological diseases: HTLV-1 associated myelopathy and multiple sclerosis
Affiliations
- PMID: 10190696
- DOI: 10.3109/13550289909029751
Item in Clipboard
Chemokines in chronic progressive neurological diseases: HTLV-1 associated myelopathy and multiple sclerosis
J Neurovirol.
1999 Feb.
Abstract
It is hypothesized that in MS and HTLV-1, chemokine and chemokine receptor expression are important mechanisms by which T cells migrate to sites of inflammation. Preliminary evidence supports the roles of several chemokines, including MIP 1beta, in mediating the enhanced migration capacity of MS derived PBLs. In addition, the ligand CCR-5 seems to be up regulated on PBLs from some MS patients. Analysis of T cell clones does not reveal a definite correlation between cytokine phenotype and chemokine receptor profile. The chemokines and chemokine receptor family are likely to be important molecules in chronic progressive neurological diseases, in which immune cells invade the central nervous system.
Similar articles
-
Human T lymphotropic virus type I (HTLV-I)-specific T helper cell responses from HTLV-I seronegative patients with chronic myelopathy and MS in Japan.Mult Scler. 1996 Feb;1(4):200-3. Mult Scler. 1996. PMID: 9345434 Clinical Trial.
-
Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state.Clin Exp Immunol. 2006 Aug;145(2):296-301. doi: 10.1111/j.1365-2249.2006.03150.x. Clin Exp Immunol. 2006. PMID: 16879249 Free PMC article.
-
Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.J Neurol. 2002 May;249(5):576-83. doi: 10.1007/s004150200067. J Neurol. 2002. PMID: 12021948
-
[Chemokines and chemokine receptors in multiple sclerosis].Nihon Rinsho. 2003 Aug;61(8):1422-7. Nihon Rinsho. 2003. PMID: 12962033 Review. Japanese.
-
Pathogenesis of chronic progressive myelopathy associated with human T-cell lymphotropic virus type I.Acta Neurol Scand Suppl. 1997;169:86-93. doi: 10.1111/j.1600-0404.1997.tb08156.x. Acta Neurol Scand Suppl. 1997. PMID: 9174644 Review.
Cited by
-
CCL5-Glutamate Cross-Talk in Astrocyte-Neuron Communication in Multiple Sclerosis.Front Immunol. 2017 Sep 4;8:1079. doi: 10.3389/fimmu.2017.01079. eCollection 2017. Front Immunol. 2017. PMID: 28928746 Free PMC article. Review.
-
Chemokines and viral diseases of the central nervous system.Adv Virus Res. 2001;56:127-73. doi: 10.1016/s0065-3527(01)56006-6. Adv Virus Res. 2001. PMID: 11450298 Free PMC article. Review.
-
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS.J Clin Invest. 2003 Jun;111(11):1703-13. doi: 10.1172/JCI16921. J Clin Invest. 2003. PMID: 12782673 Free PMC article.
-
Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis.J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):498-502. doi: 10.1136/jnnp.72.4.498. J Neurol Neurosurg Psychiatry. 2002. PMID: 11909910 Free PMC article.
-
CCR5Δ32 Polymorphism Associated with a Slower Rate Disease Progression in a Cohort of RR-MS Sicilian Patients.Mult Scler Int. 2011;2011:153282. doi: 10.1155/2011/153282. Epub 2011 Jun 23. Mult Scler Int. 2011. PMID: 22096627 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical